Table 1.
Treatment |
Posttreatment |
Long-term follow-up |
||||
Frequency | Time | Frequency | Time | Frequency | Time | |
1 | 38%a | 57%a | +17%a,b | 39%a | 33% | 46% |
2 | 55%a | 37%a | 30%a | 22%a | 58% | 43% |
3 | 90%a | 97%a | 76%a | 87%a | 90% | 97% |
4 | 35%a | 44%a | 48%a | 53%a | 52% | 55% |
5 | 81%a | 94%a | 8%a | 49%a | 19% | 61% |
6 | 44%a | 56%a | 44%a | 72%a | — | — |
7 | 4%a | 4%a | 59%a | 49%a | — | — |
8 | 77% | 89% | — | — | — | — |
Reductions are relative to baseline values; macaques 1 through 6 were considered to be responders. Data from macaque 8 were excluded from statistical analysis due to clinical illness.aP < 0.025 compared with baseline value.bThis value represents an increase in the frequency of SIB. |